Mild Encephalopathy with Reversible Splenic Lesions in an Infant with COVID-19

Authors

  • Natsuki Yagi Department of Paediatrics, Japanese Red Cross Maebashi Hospital, 389-1 Asakuramachi, Maebashi, Gunma 371-0811, Japan
  • Ryo Sugitate Department of Paediatrics, Japanese Red Cross Maebashi Hospital, 389-1 Asakuramachi, Maebashi, Gunma 371-0811, Japan
  • Mariko Shimizu Department of Paediatrics, Japanese Red Cross Maebashi Hospital, 389-1 Asakuramachi, Maebashi, Gunma 371-0811, Japan
  • Tomomi Ogata Department of Paediatrics, Gunma University Graduate School of Medicine, Chome - 39-22 Showamachi, Maebashi, Gunma 371-0034, Japan

DOI:

https://doi.org/10.60086/jnps498

Abstract

There have been few reports of mild encephalopathy with reversible splenic lesions (MERS) associated with COVID-19 in infants. Here, we present a case of MERS in a 23-month-old infant with COVID-19 in Japan during the Omicron variant epidemic. The increase in COVID-19 acute encephalopathy in infants, including those with MERS, should be considered in the future due to the prevalence of the Omicron variant strain. Meanwhile, whether the cause is COVID-19, acute encephalopathy with a lesion localized in the splenium of the corpus callosum can be treated with temporary anticonvulsant therapy, as is generally the case with MERS.

Downloads

Download data is not yet available.
Abstract
83
PDF
44

Downloads

Published

2023-09-10

How to Cite

Yagi, N. ., Sugitate, R. ., Shimizu, M. ., & Ogata, T. . (2023). Mild Encephalopathy with Reversible Splenic Lesions in an Infant with COVID-19 . Journal of Nepal Paediatric Society, 43(1), 105–107. https://doi.org/10.60086/jnps498

Issue

Section

Brief Reports/Case Reports/Case Series